The main tumor suppressive function originally attributed to CDK2AP1/DOC1 lies in its role as a negative regulator of the cell cycle through the inhibition of cyclin-dependent kinase 2 (CDK2) and DNA polymerase alpha/primase during the S-phase [2]. This evidence concerns the gene CDK2AP1 and neoplasm.